Verified

Wylie Scholar Award

Foundation to Advance Vascular Cures

The 2026 Foundation to Advance Vascular Cures Wylie Scholar award is a 1-year, $50,000 grant designed to support outstanding young vascular surgeon-scientists who are dedicated to an academic career combining their clinical practice with original, innovative research. The award may be subject to renewal for a second year. The Foundation is committed to advancing the field through the development of the next generation of leading vascular surgeon-scientists and envisions that this award will enable the awardee to do impactful vascular research early in their career, thereby helping the recipient to qualify for independent funding from national health agencies and other state and foundation awards. The 2026 Wylie Scholar will be given the opportunity to be paired with a former Wylie Scholar who will serve as a mentor/advisor and provide research project guidance.

Award Uses

The award may be used to support research in the following areas:

Basic science, translational, clinical research, patient-centered research, outcomes/health services research, teaching, community service, and patient care. Please note that the Foundation to Advance Vascular Cures does not pay indirect costs.

AI Based Application Success Predictor

1. Direct relevance to vascular disease (Highest Predictor ⭐⭐⭐⭐⭐)

This is the single most important success factor.

Competitive proposals should focus on vascular diseases such as:

Peripheral artery disease (PAD)
Critical limb ischemia (CLI)/chronic limb-threatening ischemia (CLTI)
Aortic aneurysm
Carotid artery disease
Venous disease
Vascular trauma
Diabetic vascular complications
Microvascular disease
Vascular regeneration
Limb preservation
Endovascular therapies

Projects outside vascular medicine or surgery are generally not competitive.

2. Strong potential to improve patient outcomes (Highest Predictor ⭐⭐⭐⭐⭐)

FAVC emphasizes research that can directly benefit patients.

Competitive proposals should demonstrate potential to:

Prevent limb loss
Improve vascular health
Improve diagnosis
Enhance treatment effectiveness
Reduce complications
Improve functional outcomes
Improve quality of life

Projects with a clear pathway to improving vascular care receive the strongest consideration.

3. Strong translational and clinical relevance (Highest Predictor ⭐⭐⭐⭐⭐)

A defining feature of FAVC funding is the emphasis on translating discoveries into clinical practice.

Competitive proposals often include:

Translational vascular biology
Device development
Biomarker validation
Regenerative medicine
Cell-based therapies
Clinical research
Comparative effectiveness research
Implementation science

Projects should clearly describe how discoveries will improve patient care.

4. Innovation and originality (Very High Predictor ⭐⭐⭐⭐⭐)

Competitive applications frequently investigate:

Novel vascular therapies
Precision vascular medicine
Artificial intelligence
Advanced imaging
Regenerative therapies
Tissue engineering
Endovascular technologies
Digital health solutions

Innovative projects with high clinical relevance are particularly competitive.

5. Scientific excellence and rigorous methodology (Very High Predictor ⭐⭐⭐⭐⭐)

Competitive proposals demonstrate:

Important research questions
Strong biological or clinical rationale
Appropriate study design
Robust statistical analysis
Clearly defined endpoints
Realistic milestones

Methodological rigor is a key element of peer review.

6. Early-career investigator development (Very High Predictor ⭐⭐⭐⭐⭐)

FAVC has historically invested in developing future leaders in vascular research.

Competitive applicants often include:

Vascular surgery fellows
Junior faculty
Early-stage clinician-scientists
Early-career vascular medicine investigators

Reviewers evaluate leadership potential and commitment to vascular research.

7. Strong mentorship and collaborative research environment (High Predictor ⭐⭐⭐⭐☆)

Competitive applications benefit from:

Experienced mentors
Multidisciplinary collaborations
Strong institutional support
Access to vascular patient populations
Appropriate research infrastructure

Mentorship is particularly important for career-development awards.

8. Feasible project design and realistic implementation (High Predictor ⭐⭐⭐⭐☆)

Successful proposals demonstrate:

Achievable objectives
Realistic timelines
Appropriate budgets
Risk management
Available resources

Pilot studies should be appropriately scaled to the available funding.

9. Potential to generate future external funding (High Predictor ⭐⭐⭐⭐☆)

FAVC awards are intended to serve as seed funding.

Competitive projects should generate:

Preliminary data
NIH/NHLBI grant applications
Larger multicenter studies
Long-term vascular research programs

A clear strategy for future funding strengthens an application.

10. Dissemination and impact on vascular practice (High Predictor ⭐⭐⭐⭐☆)

Competitive proposals should demonstrate potential to:

Publish in peer-reviewed journals
Present at vascular surgery meetings
Influence clinical guidelines
Improve standards of vascular care
Advance evidence-based vascular medicine

Broad dissemination increases the long-term impact of the research.

Specialties

Vascular Surgery

Eligibility Requirements

Candidates must hold a full-time faculty appointment as a vascular surgeon with active privileges at a medical school accredited by the Liaison Committee on Medical Education in the United States or the Committee for the Accreditation of Canadian Medical Schools in Canada.

The candidate must be an active, practicing clinical vascular surgeon.

The following conditions must be met:

The candidate must have completed a Vascular Surgery Board of the American Board of Surgery or Royal College of Physicians and Surgeons of Canada approved Vascular Surgery training program, and be board-eligible or board-certified in Vascular Surgery.

The candidate must be within 3 years of their first faculty appointment at the time of application. The candidate must be confirmed faculty at the time of application.

The candidate must be an active, practicing clinical vascular surgeon.

The candidate must present convincing evidence of rigorous research training and significant research accomplishments to date.

The Wylie Scholar Program is intended to support outstanding vascular surgeon scientists in the initial phases of their academic careers to accomplish the groundwork needed to be competitive for national career development awards or other independent funding.

To be eligible to apply, at the time of application, the candidate must not be funded or have notice of funding that will start after the time of application by any of the career development awards listed below or by any other single or multi-year award that exceeds $50,000:

Veterans Affairs CDA or RDA or alternatively named program with similar level of research funding

American Heart Association, or similar extramural research funding agencies

NIH R01 or R21

Individual K awards (KL2 institutional awards are not disqualifiers)

Disclosures:

Up and until the award notice is made, the candidate must disclose prior and existing individual awards and/or funds received to support their research. Failure to disclose will be grounds for rescission of the award. Concomitant awards similar in size to the Wylie Scholar will be considered on an individual basis. Examples include but are not limited to:

Awards from professional societies such as the American College of Surgeons

Young faculty awards via professional societies

NIH small grant program R03

In the event that an investigator has been given an award or notice of an award that has substantive overlap, the investigator is required to disclose such overlap.

The candidate must disclose any and all grant applications that have been submitted that run concurrently with the Wylie Scholar Award.

Prior to the initial disbursement of funds, the awardee must disclose any new funding received after the application process.

The amount of current and previously awarded funding will be taken into consideration by the Wylie Scholar Award Review Committee and may be grounds for rescinding the award, as the award is designed to provide crucial early funding to promising surgeon scientists. The Committee will review all disclosures and determine continued eligibility on a case-by-case basis.

The candidate must have a research mentor who will be an additional resource for his or her research.

The Chairman of the Department of Surgery must guarantee that the candidate will have 25% protected time available to devote to the research investigation, and to commit to provide matching support in the form of funds, facilities, equipment and/or resources to execute the proposed studies. These resources can be shared with the candidate’s mentor, but their availability and location should be clearly described.

The 2026 Wylie Scholar is required to participate in a Foundation to Advance Vascular Cures event during their research grant tenure at which they will present their work and meet with the Foundation’s CMO to support their scientific mentorship and training. The Foundation will discuss and decide with the awardee which event is most appropriate. Up to $2,000 of the annual stipend may be used for travel expenses and two nights of lodging; in the event that the awardee does not attend an event, the funds allocated for travel will be forfeited.

If funds are available, the 2026 Wylie Scholar can reapply for a second year award.

Eligible Countries:

Canada

United States

Sponsor Details

Sponsor Institute/Organizations: Foundation to Advance Vascular Cures

Sponsor Type: Corporate/Non-Profit

Address: 274 Redwood Shores Parkway #717 Redwood City, CA 94065

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity